Avisos
Vaciar todo
COVID-19
1
Respuestas
1
Usuarios
0
Reactions
147
Visitas
Ene 19, 2021 6:26 pm
-
La multinacional ultima una inmunoglobulina anti-SARS-CoV-2 de administración subcutánea
![Más información](data:image/svg+xml,%3Csvg xmlns="http://www.w3.org/2000/svg" width="24" height="24" preserveAspectRatio="xMidYMid meet" viewBox="0 0 1024 1024"%3E%3Cpath fill="%23a7a7a7" d="M512 64a448 448 0 1 1 0 896.064A448 448 0 0 1 512 64zm67.2 275.072c33.28 0 60.288-23.104 60.288-57.344s-27.072-57.344-60.288-57.344c-33.28 0-60.16 23.104-60.16 57.344s26.88 57.344 60.16 57.344zM590.912 699.2c0-6.848 2.368-24.64 1.024-34.752l-52.608 60.544c-10.88 11.456-24.512 19.392-30.912 17.28a12.992 12.992 0 0 1-8.256-14.72l87.68-276.992c7.168-35.136-12.544-67.2-54.336-71.296c-44.096 0-108.992 44.736-148.48 101.504c0 6.784-1.28 23.68.064 33.792l52.544-60.608c10.88-11.328 23.552-19.328 29.952-17.152a12.8 12.8 0 0 1 7.808 16.128L388.48 728.576c-10.048 32.256 8.96 63.872 55.04 71.04c67.84 0 107.904-43.648 147.456-100.416z"/%3E%3C/svg%3E%0A)
![](data:image/svg+xml,%3Csvg xmlns="http://www.w3.org/2000/svg" width="24" height="24" preserveAspectRatio="xMidYMid meet" viewBox="0 0 16 16"%3E%3Cpath fill="none" stroke="%23a7a7a7" stroke-linecap="round" stroke-linejoin="round" stroke-width="1.5" d="m11.25 4.75l-6.5 6.5m0-6.5l6.5 6.5"/%3E%3C/svg%3E%0A)